Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra A Denisova

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Recent Patents on Anti-Cancer Drug Discovery|June 20, 2022
Clinical CDK2 Inhibitors: Trends to Selectivity and EfficacyPolina V Rusina, Alexey A Lisov, Alexandra A Denisova, et al.
Iscience|June 27, 2022
APOBEC mutagenesis is low in most types of non-B DNA structuresGennady V Ponomarev, Bulat Fatykhov, Vladimir A Nazarov, et al.
Molecules (Basel, Switzerland)|November 13, 2021
A New Class of Uracil-DNA Glycosylase Inhibitors Active against Human and Vaccinia Virus EnzymeInga R Grin, Grigory V Mechetin, Rustem D Kasymov, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Recent Patents on Anti-Cancer Drug Discovery|June 20, 2022
Clinical CDK2 Inhibitors: Trends to Selectivity and EfficacyPolina V Rusina, Alexey A Lisov, Alexandra A Denisova, et al.
Iscience|June 27, 2022
APOBEC mutagenesis is low in most types of non-B DNA structuresGennady V Ponomarev, Bulat Fatykhov, Vladimir A Nazarov, et al.
Molecules (Basel, Switzerland)|November 13, 2021
A New Class of Uracil-DNA Glycosylase Inhibitors Active against Human and Vaccinia Virus EnzymeInga R Grin, Grigory V Mechetin, Rustem D Kasymov, et al.
Pageof 1